iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Shares Down 0.3% – Should You Sell?

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA)’s stock price were down 0.3% during mid-day trading on Tuesday . The company traded as low as $25.32 and last traded at $25.36. Approximately 17,547 shares were traded during mid-day trading, a decline of 41% from the average daily volume of 29,520 shares. The stock had previously closed at $25.43.

iShares Genomics Immunology and Healthcare ETF Stock Down 0.3%

The stock has a 50-day simple moving average of $23.50 and a 200-day simple moving average of $21.73. The firm has a market capitalization of $128.07 million, a PE ratio of 14.76 and a beta of 1.07.

Institutional Trading of iShares Genomics Immunology and Healthcare ETF

A number of large investors have recently bought and sold shares of IDNA. Cambridge Investment Research Advisors Inc. increased its position in iShares Genomics Immunology and Healthcare ETF by 4.0% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 19,797 shares of the company’s stock worth $406,000 after buying an additional 756 shares during the last quarter. Portland Global Advisors LLC bought a new position in shares of iShares Genomics Immunology and Healthcare ETF in the second quarter worth $2,099,000. Finally, Flow Traders U.S. LLC bought a new position in shares of iShares Genomics Immunology and Healthcare ETF in the second quarter worth $931,000.

About iShares Genomics Immunology and Healthcare ETF

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.